Assenagon Asset Management
WVE icon

Assenagon Asset Management’s Wave Life Sciences WVE Stock Holding History

Assenagon Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,005
Closed -$104K – 1380
2020
Q2 		$104K Buy
+10,005
New +$94.1K ﹤0.01% 1088
2020
Q1 		– Sell
-67,140
Closed -$538K – 1023
2019
Q4 		$538K Buy
+67,140
New +$1.65M ﹤0.01% 651
2019
Q3 		– Sell
-22,311
Closed -$582K – 1094
2019
Q2 		$582K Buy
+22,311
New +$626K ﹤0.01% 823

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Assenagon Asset Management's WVE Position: Q3 2020 in Review

Assenagon Asset Management sold out of Wave Life Sciences (WVE) in Q3 2020, closing a stake of 10,005 shares — an estimated $104K sold.

Assenagon Asset Management first reported a position in WVE in Q2 2019 and held it in 3 quarters. The position peaked at $582K in Q2 2019. 110 funds tracked by Wall St. Rank hold WVE as of Q3 2020.

  • Assenagon Asset Management reported no remaining Wave Life Sciences position as of Q3 2020 after selling out during the quarter.
  • Assenagon Asset Management sold 10,005 Wave Life Sciences shares in Q3 2020, an estimated $104K.
  • Assenagon Asset Management first reported a position in Wave Life Sciences in Q2 2019 and held it in 3 quarters.
  • Assenagon Asset Management's Wave Life Sciences position peaked at $582K in Q2 2019.
  • 110 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2020.

Based on Assenagon Asset Management's 13F filing for Q3 2020, filed 7 Oct 2020.